Press release and another news release from the Binatyara Foundation, USA & the Binaytara Foundation Cancer Center, Janakpurdham, Nepal.
By: Tiantian Zhang1, Yiqun Han2, Lei Deng3 1. Department of Internal Medicine, University of Central Florida, Pensacola, FL 2. Mayo…
By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 23, 2024, the U.S. Food and Drug Administration granted accelerated approval for…
By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 29, 2024, the U.S. Food and Drug Administration granted regular approval to…
By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 23, 2024, the U.S. Food and Drug Administration granted approval for lutetium…
By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 18, 2024, the U.S. Food and Drug Administration granted approval to a…
By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 22, 2024, the U.S. Food and Drug Administration granted approval for nogapendekin…
Presented by: Dr. Stephen S. Grubbs As we look at quality through value-based solutions, there are many perspectives to…
By: Dr. Anish ShahBronx-Lebanon Hospital; Bronx, NY On April 5, 2024, the Food and Drug Administration granted accelerated approval forfam-trastuzumab deruxtecan-nxki (Enhertu, Daiichi…
By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On March 1, 2024, the U.S. Food and Drug Administration approved amivantamab- vmjw (Rybrevant,…
By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY The FDA gave its approval for the use of osimertinib (Tagrisso, AstraZeneca Pharmaceuticals LP)…